This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange gained 1.15 points to 809.74 Monday. Ian Burns's capital pool shell, Montreux Capital Corp., has completed its qualifying transaction by acquiring Assure Neuromonitoring LLC, a medical device company in Colorado. The shell rolled back 1 for 3, which left it with 4,136,333 postconsolidated shares issued, then it issued 24 million postconsolidated shares to its target's shareholders. The shell and its target also sold a $3.19-million private placement of 6,392,060 (postconsolidated) subscription receipts at 50 cents. Today, the resulting issuer began trading as Assure Holdings Corp. (IOM). It reached an intraday high of $1.20 before closing at $1.08 on 1.07 million shares.

Assure Holdings, carrying on the business of Assure Neuromonitoring, offers equipment and technical services for monitoring a patient's nervous system during a surgery, particularly a surgery on the brain or spine. Most of Assure's customers are in Colorado, but the company plans to expand throughout the Midwest. In 2016, it earned $4.01-million (U.S.) on revenue of $5.52-million (U.S.). This was the first year in which it had revenue. Depending on the achievement of performance goals, Assure Holdings may issue another six million postconsolidated shares to the former shareholders of Assure Neuromonitoring. The public company will release its first quarter financial results on Wednesday, after the market closes.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS